HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib

HER2 mutations have emerged as oncogenic driver gene mutations in non-small cell lung cancer (NSCLC), which have not been described in detail like other driver gene mutations. Here, 295 patients with advanced lung adenocarcinoma were retrospectively screened for HER2 mutations using next-generation...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Front Oncol
Huvudupphovsmän: Zhang, Xinyong, Lv, Jialin, Wu, Yuhua, Qin, Na, Ma, Li, Li, Xi, Nong, Jingying, Zhang, Hui, Zhang, Quan, Yang, Xinjie, Shi, Huibo, Wang, Jinghui, Zhang, Shucai
Materialtyp: Artigo
Språk:Inglês
Publicerad: Frontiers Media S.A. 2020
Ämnen:
Oncology
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7411254/
https://ncbi.nlm.nih.gov/pubmed/32850330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01162
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk